{"id":"arxiv:1704.03027","kind":"article","title":"Data-Driven Prediction of CRISPR-Based Transcription Regulation for Programmable Control of Metabolic Flux","authors":["Jiayuan Sheng","Weihua Guo","Christine Ash","Brendan Freitas","Mitchell Paoletti","Xueyang Feng"],"author_count":6,"year":2017,"published":"2017-04-10","venue":"bioRxiv (Cold Spring Harbor Laboratory)","cited_by":2,"doi":"10.1101/119396","arxiv_id":"1704.03027","nct_id":null,"source_url":"https://arxiv.org/abs/1704.03027","archive_url":"https://space-kitty.com/papers/arxiv:1704.03027","updated":"2017-04-10","pmid":null,"pmcid":null,"openalex_id":"W2604573868","pdf_url":"https://arxiv.org/pdf/1704.03027","abstract":"Multiplex and multi-directional control of metabolic pathways is crucial for metabolic engineering to improve product yield of fuels, chemicals, and pharmaceuticals. To achieve this goal, artificial transcriptional regulators such as CRISPR-based transcription regulators have been developed to specifically activate or repress genes of interest. Here, we found that by deploying guide RNAs to target on DNA sites at different locations of genetic cassettes, we could use just one synthetic CRISPR-based transcriptional regulator to simultaneously activate and repress gene expressions. By using the pairwise datasets of guide RNAs and gene expressions, we developed a data-driven predictive model to rationally design this system for fine-tuning expression of target genes. We demonstrated that this system could achieve programmable control of metabolic fluxes when using yeast to produce versatile chemicals. We anticipate that this master CRISPR-based transcription regulator will be a valuable addition to the synthetic biology toolkit for metabolic engineering, speeding up the design-build-test cycle in industrial biomanufacturing as well as generating new biological insights on the fates of eukaryotic cells.","abstract_license":"CC0-1.0 (arXiv descriptive metadata)","license":null,"is_open_access":false,"peer_reviewed":null,"categories":["q-bio.BM","q-bio.GN"],"details":null,"provenance":"arxiv","attribution":"Abstract: arXiv descriptive metadata (CC0). Thank you to arXiv for use of its open access interoperability. This service was not reviewed or approved by, nor does it necessarily express or reflect the policies or opinions of, arXiv.","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"},{"slug":"synthetic-biology","name":"Synthetic Biology & Genome Engineering","domain_slug":"biotech"}],"cited_in_dossiers":[]}